Team:Stanford/ModelingPage
From 2009.igem.org
Yanghemary (Talk | contribs) (→Anti-Inflammatory Device) |
Yanghemary (Talk | contribs) |
||
Line 15: | Line 15: | ||
==Anti-Inflammatory Device== | ==Anti-Inflammatory Device== | ||
- | + | <h1>The IPP-->B-carotene-->RA Model</h1> | |
- | + | [[Image:IPP_RA Model.jpg|600px|center|Fig 2.1 A quick sketch of the IPP-->RA process]] | |
+ | <center>Fig 2.1 A quick sketch of the IPP-->RA process</center> | ||
+ | |||
+ | <br><br> | ||
+ | [[Image:B-caro pathway.jpg|thumb|right|Fig 2.2 The B-carotene production pathway [1]]] | ||
+ | The process above can be devided into two procedures: | ||
+ | *IPP*8-->B-carotene | ||
+ | *B-carotene(+Blh)-->Retinal(+RalDH)-->Retinoic Acid | ||
+ | |||
+ | <br> | ||
+ | |||
+ | ==Modeling on the production of B-carotene== | ||
<br>The process of IPP producing B-carotene is quite complex, as shown in the Fig 2.2. | <br>The process of IPP producing B-carotene is quite complex, as shown in the Fig 2.2. | ||
<br>In this process, we basically care about two main issues: | <br>In this process, we basically care about two main issues: | ||
Line 22: | Line 33: | ||
# Velocity of the whole process | # Velocity of the whole process | ||
- | <h3> | + | <h3>Yield output of B-carotene</h3> |
We found the B-carotene distribution in yeast in [1]. Below is an important form as to the issue.<br> | We found the B-carotene distribution in yeast in [1]. Below is an important form as to the issue.<br> | ||
[[Image:B-caro distribution.jpg|800px|center]] | [[Image:B-caro distribution.jpg|800px|center]] | ||
Line 28: | Line 39: | ||
<br>Basically, using the cluster of "YB/I/E I", in the final product of caronoids, we get 68% of B-carotene, highest percentage in the paper. (Also 29% Phytoene, and 3% Neurosporene.) "YB/I/E tHMG1 I", producing 52% of B-carotene, might be another choice. | <br>Basically, using the cluster of "YB/I/E I", in the final product of caronoids, we get 68% of B-carotene, highest percentage in the paper. (Also 29% Phytoene, and 3% Neurosporene.) "YB/I/E tHMG1 I", producing 52% of B-carotene, might be another choice. | ||
- | <h3> | + | <h3>Production rate of B-carotene</h3> |
As this is a really long process....Basically, the velocity is mainly dependent on the most time-consuming reaction in the whole chain. Thus, Leon and I looked for the kcat values of different enzymes in the procedure, as shown in the cart below:<br> | As this is a really long process....Basically, the velocity is mainly dependent on the most time-consuming reaction in the whole chain. Thus, Leon and I looked for the kcat values of different enzymes in the procedure, as shown in the cart below:<br> | ||
[[Image:B-caro para.jpg|center]] | [[Image:B-caro para.jpg|center]] | ||
Line 35: | Line 46: | ||
[[Image:velocity of B-caro production.jpg]] | [[Image:velocity of B-caro production.jpg]] | ||
- | == | + | ==Modeling on the B-carotene-->RA process== |
The production of RA is mainly based on a chain of two catalyzed reactions, as shown in the graph below:<br> | The production of RA is mainly based on a chain of two catalyzed reactions, as shown in the graph below:<br> | ||
[[Image:B-caro_RA.jpg|400px|center]] | [[Image:B-caro_RA.jpg|400px|center]] | ||
Line 43: | Line 54: | ||
<center>Form 2.3 Parameters used in the B-carotene-->RA model</center> | <center>Form 2.3 Parameters used in the B-carotene-->RA model</center> | ||
- | == | + | ==Simulation and Analysis== |
*Equations for the IPP-->RA process: | *Equations for the IPP-->RA process: | ||
[[Image:IPP_RA equation.jpg|800px]] | [[Image:IPP_RA equation.jpg|800px]] |
Revision as of 14:30, 19 October 2009
Home | Project | Modeling | Parts | Notebook | Team | SBOL-V |
<center>
Our modeling team consisted of Leon Lin and Mary Yang.
Contents |
Goal
- To model and optimize the kinetics of these devices.
- Population dynamics: analyze the conditions to switch between Th17 and Tregs.
- To predict the results of experiments which we could not perform in the lab
Anti-Inflammatory Device
The IPP-->B-carotene-->RA Model
<center>Fig 2.1 A quick sketch of the IPP-->RA process</center>
The process above can be devided into two procedures:
- IPP*8-->B-carotene
- B-carotene(+Blh)-->Retinal(+RalDH)-->Retinoic Acid
Modeling on the production of B-carotene
The process of IPP producing B-carotene is quite complex, as shown in the Fig 2.2.
In this process, we basically care about two main issues:
- Yield output of B-carotene ([B-carotene]/[All Caronoids]).
- Velocity of the whole process
Yield output of B-carotene
We found the B-carotene distribution in yeast in [1]. Below is an important form as to the issue.
<center>Form 2.1 B-carotene distribution [1]</center>
Basically, using the cluster of "YB/I/E I", in the final product of caronoids, we get 68% of B-carotene, highest percentage in the paper. (Also 29% Phytoene, and 3% Neurosporene.) "YB/I/E tHMG1 I", producing 52% of B-carotene, might be another choice.
Production rate of B-carotene
As this is a really long process....Basically, the velocity is mainly dependent on the most time-consuming reaction in the whole chain. Thus, Leon and I looked for the kcat values of different enzymes in the procedure, as shown in the cart below:
<center>Form 2.2 Paremeters in the IPP-->B-carotene model. (Source: mostly from Brenda)</center>
Apparently, cyclization of Lycopene is the slowest reaction, as the concentration of enzymes are approximately in the same level.
Modeling on the B-carotene-->RA process
The production of RA is mainly based on a chain of two catalyzed reactions, as shown in the graph below:
<center>Fig 2.3 The production of RA</center>
Neither Retinal nor RA has any other degrading process in E.coli. Degrading rate of B-carotene is 9.769e-9 s^-1. Other paremeters we use in this model are shown in the form below:
<center>Form 2.3 Parameters used in the B-carotene-->RA model</center>
Simulation and Analysis
- Equations for the IPP-->RA process:
References
[1] High-Level Production of Beta-Carotene in Saccharomyces cerevisiae by Successive Transformation with Carotenogenic Genes from Xanthophyllomyces dendrorhous. APPLIED AND ENVIRONMENTAL MICROBIOLOGY, July 2007, p. 4342–4350
- NO->SoxS-SoxR Model
Anti-Immunosuppresion Device
</center>
File:Project Overview.jpg